These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hormone-releasing silicone-rubber intrauterine contraceptive devices. Effect of incorporation of various compounds on intrauterine contraceptive devices in rats. Doyle LL Am J Obstet Gynecol; 1975 Feb; 121(3):405-11. PubMed ID: 1115155 [TBL] [Abstract][Full Text] [Related]
4. Intravaginal and intracervical devices for the delivery of fertility regulating agents. J Steroid Biochem; 1979 Jul; 11(1B):461-7. PubMed ID: 491617 [TBL] [Abstract][Full Text] [Related]
5. Effects of two low-dose oral contraceptives on serum lipids and lipoproteins: differential changes in high-density lipoprotein subclasses. Krauss RM; Roy S; Mishell DR; Casagrande J; Pike MC Am J Obstet Gynecol; 1983 Feb; 145(4):446-52. PubMed ID: 6401927 [TBL] [Abstract][Full Text] [Related]
6. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles. Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins. Goldzieher JW; de la Peña A; Chenault CB; Cervantes A Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928 [TBL] [Abstract][Full Text] [Related]
8. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism. Godsland IF; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V N Engl J Med; 1990 Nov; 323(20):1375-81. PubMed ID: 2146499 [TBL] [Abstract][Full Text] [Related]
9. Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol and d-norgestrel. Mishell DR; Moore DE; Roy S; Brenner PF; Page MA Am J Obstet Gynecol; 1978 Jan; 130(1):55-62. PubMed ID: 619648 [TBL] [Abstract][Full Text] [Related]
10. Subdermal norethindrone pellets -- a method for contraception? Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813 [TBL] [Abstract][Full Text] [Related]
11. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404 [TBL] [Abstract][Full Text] [Related]
12. Changes in unbound sex steroids and sex hormone binding globulin--binding capacity during oral and vaginal progestogen administration. Granger LR; Roy S; Mishell DR Am J Obstet Gynecol; 1982 Nov; 144(5):578-84. PubMed ID: 6890312 [TBL] [Abstract][Full Text] [Related]
13. Bleeding and serum d-norgestrel, estradiol and progesterone patterns in women using d-norgestrel subdermal polysiloxane capsules for contraception. Moore DE; Roy S; Stanczyk FZ; Mishell DR Contraception; 1978 Apr; 17(4):315-28. PubMed ID: 648154 [TBL] [Abstract][Full Text] [Related]
14. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel. Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174 [TBL] [Abstract][Full Text] [Related]
15. The progestational activity of different gestagens used for human contraception in the beagle bitch. Beier S; Haase F; Kosub B; Düsterberg B; Elger W Contraception; 1979 Dec; 20(6):533-48. PubMed ID: 94000 [No Abstract] [Full Text] [Related]
16. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment. Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the potency of orally administered progestins in women. King RJ; Whitehead MI Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605 [TBL] [Abstract][Full Text] [Related]
18. Cross-reaction of contraceptive steroids in competitive binding assays of progesterone and estradiol. Kharma K; Stone S; Thorneycroft IH; Nakamura RM; Mishell DR Am J Obstet Gynecol; 1972 Mar; 112(5):676-80. PubMed ID: 4110418 [TBL] [Abstract][Full Text] [Related]
19. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. Notelovitz M; Kitchens CS; Khan FY Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974 [TBL] [Abstract][Full Text] [Related]
20. Steroid hormones and the fertilizing capacity of spermatozoa. Briggs MH Steroids; 1973 Oct; 22(4):547-53. PubMed ID: 4127001 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]